866-997-4948(US-Canada Toll Free)

United States Transdermal Patch Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 96 Pages

In this report, the United States Transdermal Patch market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Transdermal Patch in these regions, from 2012 to 2022 (forecast).

United States Transdermal Patch market competition by top manufacturers/players, with Transdermal Patch sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Clonidine Transdermal Patch
Buprenorphine Transdermal Patch
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Transdermal Patch for each application, including
Relieve Severe Pain
Stop Smoking Cigarettes
Treat An Overactive Bladder
Others

Table of Contents

United States Transdermal Patch Market Report 2017
1 Transdermal Patch Overview
1.1 Product Overview and Scope of Transdermal Patch
1.2 Classification of Transdermal Patch by Product Category
1.2.1 United States Transdermal Patch Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Transdermal Patch Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Fentanyl Transdermal Patch
1.2.4 Nicotine Transdermal Patch
1.2.5 Clonidine Transdermal Patch
1.2.6 Buprenorphine Transdermal Patch
1.3 United States Transdermal Patch Market by Application/End Users
1.3.1 United States Transdermal Patch Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Relieve Severe Pain
1.3.3 Stop Smoking Cigarettes
1.3.4 Treat An Overactive Bladder
1.3.5 Others
1.4 United States Transdermal Patch Market by Region
1.4.1 United States Transdermal Patch Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Transdermal Patch Status and Prospect (2012-2022)
1.4.3 Southwest Transdermal Patch Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Transdermal Patch Status and Prospect (2012-2022)
1.4.5 New England Transdermal Patch Status and Prospect (2012-2022)
1.4.6 The South Transdermal Patch Status and Prospect (2012-2022)
1.4.7 The Midwest Transdermal Patch Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Transdermal Patch (2012-2022)
1.5.1 United States Transdermal Patch Sales and Growth Rate (2012-2022)
1.5.2 United States Transdermal Patch Revenue and Growth Rate (2012-2022)

2 United States Transdermal Patch Market Competition by Players/Suppliers
2.1 United States Transdermal Patch Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Transdermal Patch Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Transdermal Patch Average Price by Players/Suppliers (2012-2017)
2.4 United States Transdermal Patch Market Competitive Situation and Trends
2.4.1 United States Transdermal Patch Market Concentration Rate
2.4.2 United States Transdermal Patch Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Transdermal Patch Manufacturing Base Distribution, Sales Area, Product Type

3 United States Transdermal Patch Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Transdermal Patch Sales and Market Share by Region (2012-2017)
3.2 United States Transdermal Patch Revenue and Market Share by Region (2012-2017)
3.3 United States Transdermal Patch Price by Region (2012-2017)

4 United States Transdermal Patch Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Transdermal Patch Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Transdermal Patch Revenue and Market Share by Type (2012-2017)
4.3 United States Transdermal Patch Price by Type (2012-2017)
4.4 United States Transdermal Patch Sales Growth Rate by Type (2012-2017)

5 United States Transdermal Patch Sales (Volume) by Application (2012-2017)
5.1 United States Transdermal Patch Sales and Market Share by Application (2012-2017)
5.2 United States Transdermal Patch Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Transdermal Patch Players/Suppliers Profiles and Sales Data
6.1 Hisamitsu Pharmaceutical
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Transdermal Patch Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novartis
6.2.2 Transdermal Patch Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis Transdermal Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson
6.3.2 Transdermal Patch Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Johnson & Johnson Transdermal Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Teikoku Pharma
6.4.2 Transdermal Patch Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Teikoku Pharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Mylan
6.5.2 Transdermal Patch Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Mylan Transdermal Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Actavis
6.6.2 Transdermal Patch Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Actavis Transdermal Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Mundipharma
6.7.2 Transdermal Patch Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Mundipharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Henan Lingrui Pharmaceutical
6.8.2 Transdermal Patch Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Henan Lingrui Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Changzhou Siyao
6.9.2 Transdermal Patch Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Changzhou Siyao Transdermal Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Rfl Pharmaceutical
6.10.2 Transdermal Patch Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Rfl Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Transdermal Patch Manufacturing Cost Analysis
7.1 Transdermal Patch Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Transdermal Patch

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Transdermal Patch Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Transdermal Patch Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Transdermal Patch Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Transdermal Patch Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Transdermal Patch Sales Volume Forecast by Type (2017-2022)
11.3 United States Transdermal Patch Sales Volume Forecast by Application (2017-2022)
11.4 United States Transdermal Patch Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Transdermal Patch
Figure United States Transdermal Patch Market Size (K Units) by Type (2012-2022)
Figure United States Transdermal Patch Sales Volume Market Share by Type (Product Category) in 2016
Figure Fentanyl Transdermal Patch Product Picture
Figure Nicotine Transdermal Patch Product Picture
Figure Clonidine Transdermal Patch Product Picture
Figure Buprenorphine Transdermal Patch Product Picture
Figure United States Transdermal Patch Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Transdermal Patch by Application in 2016
Figure Relieve Severe Pain Examples
Figure Stop Smoking Cigarettes Examples
Figure Treat An Overactive Bladder Examples
Figure Others Examples
Figure United States Transdermal Patch Market Size (Million USD) by Region (2012-2022)
Figure The West Transdermal Patch Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Transdermal Patch Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Transdermal Patch Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Transdermal Patch Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Transdermal Patch Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Transdermal Patch Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Transdermal Patch Sales (K Units) and Growth Rate (2012-2022)
Figure United States Transdermal Patch Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Transdermal Patch Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Transdermal Patch Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Transdermal Patch Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Transdermal Patch Sales Share by Players/Suppliers
Figure 2017 United States Transdermal Patch Sales Share by Players/Suppliers
Figure United States Transdermal Patch Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Transdermal Patch Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Transdermal Patch Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Transdermal Patch Revenue Share by Players/Suppliers
Figure 2017 United States Transdermal Patch Revenue Share by Players/Suppliers
Table United States Market Transdermal Patch Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Transdermal Patch Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Transdermal Patch Market Share of Top 3 Players/Suppliers
Figure United States Transdermal Patch Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Transdermal Patch Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Transdermal Patch Product Category
Table United States Transdermal Patch Sales (K Units) by Region (2012-2017)
Table United States Transdermal Patch Sales Share by Region (2012-2017)
Figure United States Transdermal Patch Sales Share by Region (2012-2017)
Figure United States Transdermal Patch Sales Market Share by Region in 2016
Table United States Transdermal Patch Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Transdermal Patch Revenue Share by Region (2012-2017)
Figure United States Transdermal Patch Revenue Market Share by Region (2012-2017)
Figure United States Transdermal Patch Revenue Market Share by Region in 2016
Table United States Transdermal Patch Price (USD/Unit) by Region (2012-2017)
Table United States Transdermal Patch Sales (K Units) by Type (2012-2017)
Table United States Transdermal Patch Sales Share by Type (2012-2017)
Figure United States Transdermal Patch Sales Share by Type (2012-2017)
Figure United States Transdermal Patch Sales Market Share by Type in 2016
Table United States Transdermal Patch Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Transdermal Patch Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Transdermal Patch by Type (2012-2017)
Figure Revenue Market Share of Transdermal Patch by Type in 2016
Table United States Transdermal Patch Price (USD/Unit) by Types (2012-2017)
Figure United States Transdermal Patch Sales Growth Rate by Type (2012-2017)
Table United States Transdermal Patch Sales (K Units) by Application (2012-2017)
Table United States Transdermal Patch Sales Market Share by Application (2012-2017)
Figure United States Transdermal Patch Sales Market Share by Application (2012-2017)
Figure United States Transdermal Patch Sales Market Share by Application in 2016
Table United States Transdermal Patch Sales Growth Rate by Application (2012-2017)
Figure United States Transdermal Patch Sales Growth Rate by Application (2012-2017)
Table Hisamitsu Pharmaceutical Basic Information List
Table Hisamitsu Pharmaceutical Transdermal Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hisamitsu Pharmaceutical Transdermal Patch Sales Growth Rate (2012-2017)
Figure Hisamitsu Pharmaceutical Transdermal Patch Sales Market Share in United States (2012-2017)
Figure Hisamitsu Pharmaceutical Transdermal Patch Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Transdermal Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Transdermal Patch Sales Growth Rate (2012-2017)
Figure Novartis Transdermal Patch Sales Market Share in United States (2012-2017)
Figure Novartis Transdermal Patch Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Transdermal Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Transdermal Patch Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Transdermal Patch Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Transdermal Patch Revenue Market Share in United States (2012-2017)
Table Teikoku Pharma Basic Information List
Table Teikoku Pharma Transdermal Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teikoku Pharma Transdermal Patch Sales Growth Rate (2012-2017)
Figure Teikoku Pharma Transdermal Patch Sales Market Share in United States (2012-2017)
Figure Teikoku Pharma Transdermal Patch Revenue Market Share in United States (2012-2017)
Table Mylan Basic Information List
Table Mylan Transdermal Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mylan Transdermal Patch Sales Growth Rate (2012-2017)
Figure Mylan Transdermal Patch Sales Market Share in United States (2012-2017)
Figure Mylan Transdermal Patch Revenue Market Share in United States (2012-2017)
Table Actavis Basic Information List
Table Actavis Transdermal Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actavis Transdermal Patch Sales Growth Rate (2012-2017)
Figure Actavis Transdermal Patch Sales Market Share in United States (2012-2017)
Figure Actavis Transdermal Patch Revenue Market Share in United States (2012-2017)
Table Mundipharma Basic Information List
Table Mundipharma Transdermal Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mundipharma Transdermal Patch Sales Growth Rate (2012-2017)
Figure Mundipharma Transdermal Patch Sales Market Share in United States (2012-2017)
Figure Mundipharma Transdermal Patch Revenue Market Share in United States (2012-2017)
Table Henan Lingrui Pharmaceutical Basic Information List
Table Henan Lingrui Pharmaceutical Transdermal Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Henan Lingrui Pharmaceutical Transdermal Patch Sales Growth Rate (2012-2017)
Figure Henan Lingrui Pharmaceutical Transdermal Patch Sales Market Share in United States (2012-2017)
Figure Henan Lingrui Pharmaceutical Transdermal Patch Revenue Market Share in United States (2012-2017)
Table Changzhou Siyao Basic Information List
Table Changzhou Siyao Transdermal Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Changzhou Siyao Transdermal Patch Sales Growth Rate (2012-2017)
Figure Changzhou Siyao Transdermal Patch Sales Market Share in United States (2012-2017)
Figure Changzhou Siyao Transdermal Patch Revenue Market Share in United States (2012-2017)
Table Rfl Pharmaceutical Basic Information List
Table Rfl Pharmaceutical Transdermal Patch Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Rfl Pharmaceutical Transdermal Patch Sales Growth Rate (2012-2017)
Figure Rfl Pharmaceutical Transdermal Patch Sales Market Share in United States (2012-2017)
Figure Rfl Pharmaceutical Transdermal Patch Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Transdermal Patch
Figure Manufacturing Process Analysis of Transdermal Patch
Figure Transdermal Patch Industrial Chain Analysis
Table Raw Materials Sources of Transdermal Patch Major Players/Suppliers in 2016
Table Major Buyers of Transdermal Patch
Table Distributors/Traders List
Figure United States Transdermal Patch Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Transdermal Patch Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Transdermal Patch Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Transdermal Patch Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Transdermal Patch Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Transdermal Patch Sales Volume (K Units) Forecast by Type in 2022
Table United States Transdermal Patch Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Transdermal Patch Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Transdermal Patch Sales Volume (K Units) Forecast by Application in 2022
Table United States Transdermal Patch Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Transdermal Patch Sales Volume Share Forecast by Region (2017-2022)
Figure United States Transdermal Patch Sales Volume Share Forecast by Region (2017-2022)
Figure United States Transdermal Patch Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *